These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1022 related articles for article (PubMed ID: 17880603)

  • 21. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay.
    O'Brien SF; Yi QL; Fan W; Fearon MA; Scalia V; Goldman M
    Transfusion; 2009 Feb; 49(2):271-7. PubMed ID: 19389210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.
    Dettori S; Candido A; Kondili LA; Chionne P; Taffon S; Genovese D; Iudicone P; Miceli M; Rapicetta M
    J Infect; 2009 Aug; 59(2):128-33. PubMed ID: 19586663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
    González R; Torres P; Castro E; Barbolla L; Candotti D; Koppelman M; Zaaijer HL; Lelie N; Allain JP; Echevarría JM
    Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
    Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
    J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission.
    El-Zayadi AR; Ibrahim EH; Badran HM; Saeid A; Moneib NA; Shemis MA; Abdel-Sattar RM; Ahmady AM; El-Nakeeb A
    Transfus Med; 2008 Feb; 18(1):55-61. PubMed ID: 18279193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of antibody to hepatitis B core antigen screening among blood donors in Eastern Saudi Arabia. Need to replace the test by HBV DNA testing.
    Panhotra BR; Al-Bahrani A; Ul-Hassan Z
    Saudi Med J; 2005 Feb; 26(2):270-3. PubMed ID: 15770304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.
    Sofian M; Aghakhani A; Izadi N; Banifazl M; Kalantar E; Eslamifar A; Ramezani A
    Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.
    Yang Z; Xu L; Liu L; Feng Q; Zhang L; Ma W; Saldanha J; Wang M; Zhao L
    Transfusion; 2013 Oct; 53(10 Pt 2):2538-44. PubMed ID: 23480568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
    Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK
    Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus DNA in serum of 'anti-HBc only'-positive healthy Lebanese blood donors: significance and possible implications.
    El-Zaatari M; Kazma H; Naboulsi-Majzoub M; Haidar M; Ramlawi F; Mahfoud Z; Ramia S
    J Hosp Infect; 2007 Jul; 66(3):278-82. PubMed ID: 17540476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
    Yoshikawa A; Gotanda Y; Minegishi K; Taira R; Hino S; Tadokoro K; Ohnuma H; Miyakawa K; Tachibana K; Mizoguchi H;
    Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges in hepatitis B detection among blood donors.
    Allain JP; Cox L
    Curr Opin Hematol; 2011 Nov; 18(6):461-6. PubMed ID: 21912252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg].
    Ren F; Li H; Zhao H
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):7-9. PubMed ID: 10322742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.
    Yoshikawa A; Gotanda Y; Itabashi M; Minegishi K; Kanemitsu K; Nishioka K;
    Vox Sang; 2005 Feb; 88(2):77-86. PubMed ID: 15720604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA; Stramer SL; Kuhns MC; Schlauder GG
    Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
    Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
    Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of hepatitis B virus DNA in hepatitis B surface antigen-negative serum by polymerase chain reaction: evaluation of different primer pairs and conditions.
    Gomes SA; Yoshida CF; Niel C
    Acta Virol; 1996 Jun; 40(3):133-8. PubMed ID: 8891092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.